Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro

Infection and Immunity

Volumn 70, Issue 2, 2002, Pages 787-793

  Guerry, Patricia ^a   Szymanski, Christine M ^a   Prendergast, Martina M ^a   Hickey, Thomas E ^a   Ewing, Cheryl P ^a   Pattarini, Dawn L ^a   Moran, Anthony P ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE GM2; GANGLIOSIDE GM3; GENE PRODUCT; LIPOOLIGOSACCHARIDE; N ACETYLGALACTOSAMINYLTRANSFERASE; OLIGOSACCHARIDE; PROTEIN CGTA; PROTEIN NEUC1; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CAMPYLOBACTER JEJUNI; CELL INVASION; CONTROLLED STUDY; GENE MUTATION; GENE STRUCTURE; GENETIC CODE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR MIMICRY; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; STRAIN DIFFERENCE; STRUCTURE ANALYSIS;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BASE SEQUENCE; CAMPYLOBACTER JEJUNI; CARBOHYDRATE SEQUENCE; CLONING, MOLECULAR; DNA, BACTERIAL; G(M2) GANGLIOSIDE; G(M3) GANGLIOSIDE; GANGLIOSIDES; GENE EXPRESSION; GENES, BACTERIAL; LIPOPOLYSACCHARIDES; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; MONOMERIC GTP-BINDING PROTEINS; MUTAGENESIS; SEQUENCE ANALYSIS, DNA; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; VARIATION (GENETICS);

EID: 0036153611     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.2.787-793.2002     Document Type: Article

References (43)

1. Lipopolysaccharides from a neuropathy-associated infection from Campylobacter jejuni serotype O:23
2. Lipopolysaccharides of Campylobacter jejuni serotype O:19: Structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome
3. Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides
4. Chemical structures of the core region of Campylobacterjejuni serotype O:2 lipopolysaccharide
5. Involvement of a plasmid in virulence of Campylobacter jejuni 81-176
6. A phase variable capsule is involved in virulence of Campylobacter jejuni 81-176
7. Experimental Campylobacter jejuni infection in humans
8. Susceptibility of Campylobacter isolates to the bactericidal activity of human serum
9. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans
10. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations
11. Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384
12. Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni
13. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels
14. Campylobacter jejuni 81-176 associates with microtubules and dynein during invasion of human intestinal cells
15. A point-source outbreak of campylobacteriosis associated with consumption of raw milk
16. 1-like lipo-oligosaccharide of Campylobacter jejuni
17. Multiple N-acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: Identification and characterization of the gene involved in sialylation of lipo-oligosaccharide
18. Molecular mimicry of host structures by lipopolysaccharides of Campylobacter and Helicobacter spp.: Implications in pathogenesis
19. Potential role of lipopolysaccharides of Campylobacter jejuni in the development of Guillain-Barré syndrome
20. Campylobacter lipopolysaccharides
21. Molecular mimicry in Campylobacter jejuni lipopolysaccharides and the development of Guillain-Barré syndrome
22. Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose
23. Campylobacterjejuni infection and the association with Guillain-Barré syndrome
24. Lipo-oligosaccharides of Campylobacter jejuni serotype O:10. Structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher syndrome and from the serotype reference strain
25. Campylobacter infections in developing countries
26. Unusual microtubule-dependent endocytosis mechanisms triggered by Campylobacter jejuni and Citrobacter freundii
27. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences
28. Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice
29. 1 ganglioside
30. 3
31. Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis
32. Instability of expression of lipooligosaccharides and their epitopes in Neisseria gonorrhoeae
33. Phase variation of lipopolysaccharide directs interconversion of invasive and immuno-resistant phenotypes of Neisseria gonorrhoeae
34. Molecular mechanisms and implications for infection of lipopolysaccharide variation in Neisseria
35. Functional characterization of an isogenic meningococcal alpha-2,3-sialyltransferase mutant: The role of lipooligosaccharide sialylation for serum resistance in serogroup B meningococci
36. Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis
37. Natural transformation in Campylobacter species
38. Adaptation of Haemophilus influenzae to acquired and innate humoral immunity based on phase variation of lipopolysaccharide
39. Bacterial lipopolysaccharides: Extraction with phenol water and further applications of the technique
40. Construction of new Campylobacter cloning vectors and a new mutational cat cassette
41. Isolation of motile and non-motile insertional mutants of Campylobacter jejuni: Role of motility in adherence and invasion of eukaryotic cells
42. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure
43. 1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher syndrome